The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Smart Pills and Drugs Delivery System Market Research Report 2024
Synopsis
Smart Pills and Drugs Delivery System refers to an intelligent drug delivery system that helps doctors and patients better manage the drug treatment process. Such systems typically consist of a smart drug (smart capsule) and a device that can help doctors and patients better understand how the drug is absorbed and how it works.
Global Smart Pills and Drugs Delivery System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Smart Pills and Drugs Delivery System market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Smart Pills and Drugs Delivery System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BD
Abbott
HCmed Innovations
Adherium
BIOCORP
Medtronic
Novartis AG
Novo Nordisk A/S
Amiko Digital Health
Boston Scientific Corporation
CeQur Simplicity
Microchip Technology
FUJIFILM Holdings Corporation
E3D Elcam Drug Delivery Devices
Koninklijke Philips N.V
H&T Presspart Manufacturing
Segment by Type
Wearable Injector
Auto Injector
Pen Injector
Others
Segment by Application
Clinic
Hospital
Home Care
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Smart Pills and Drugs Delivery System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Smart Pills and Drugs Delivery System refers to an intelligent drug delivery system that helps doctors and patients better manage the drug treatment process. Such systems typically consist of a smart drug (smart capsule) and a device that can help doctors and patients better understand how the drug is absorbed and how it works.
Global Smart Pills and Drugs Delivery System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Smart Pills and Drugs Delivery System market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Smart Pills and Drugs Delivery System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BD
Abbott
HCmed Innovations
Adherium
BIOCORP
Medtronic
Novartis AG
Novo Nordisk A/S
Amiko Digital Health
Boston Scientific Corporation
CeQur Simplicity
Microchip Technology
FUJIFILM Holdings Corporation
E3D Elcam Drug Delivery Devices
Koninklijke Philips N.V
H&T Presspart Manufacturing
Segment by Type
Wearable Injector
Auto Injector
Pen Injector
Others
Segment by Application
Clinic
Hospital
Home Care
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Smart Pills and Drugs Delivery System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Smart Pills and Drugs Delivery System Market Overview
1.1 Product Overview and Scope of Smart Pills and Drugs Delivery System
1.2 Smart Pills and Drugs Delivery System Segment by Type
1.2.1 Global Smart Pills and Drugs Delivery System Market Value Comparison by Type (2023-2029)
1.2.2 Wearable Injector
1.2.3 Auto Injector
1.2.4 Pen Injector
1.2.5 Others
1.3 Smart Pills and Drugs Delivery System Segment by Application
1.3.1 Global Smart Pills and Drugs Delivery System Market Value by Application: (2023-2029)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Care
1.3.5 Others
1.4 Global Smart Pills and Drugs Delivery System Market Size Estimates and Forecasts
1.4.1 Global Smart Pills and Drugs Delivery System Revenue 2018-2029
1.4.2 Global Smart Pills and Drugs Delivery System Sales 2018-2029
1.4.3 Global Smart Pills and Drugs Delivery System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Smart Pills and Drugs Delivery System Market Competition by Manufacturers
2.1 Global Smart Pills and Drugs Delivery System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Smart Pills and Drugs Delivery System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Smart Pills and Drugs Delivery System Average Price by Manufacturers (2018-2023)
2.4 Global Smart Pills and Drugs Delivery System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Smart Pills and Drugs Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Smart Pills and Drugs Delivery System, Product Type & Application
2.7 Smart Pills and Drugs Delivery System Market Competitive Situation and Trends
2.7.1 Smart Pills and Drugs Delivery System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Smart Pills and Drugs Delivery System Players Market Share by Revenue
2.7.3 Global Smart Pills and Drugs Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Smart Pills and Drugs Delivery System Retrospective Market Scenario by Region
3.1 Global Smart Pills and Drugs Delivery System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Smart Pills and Drugs Delivery System Global Smart Pills and Drugs Delivery System Sales by Region: 2018-2029
3.2.1 Global Smart Pills and Drugs Delivery System Sales by Region: 2018-2023
3.2.2 Global Smart Pills and Drugs Delivery System Sales by Region: 2024-2029
3.3 Global Smart Pills and Drugs Delivery System Global Smart Pills and Drugs Delivery System Revenue by Region: 2018-2029
3.3.1 Global Smart Pills and Drugs Delivery System Revenue by Region: 2018-2023
3.3.2 Global Smart Pills and Drugs Delivery System Revenue by Region: 2024-2029
3.4 North America Smart Pills and Drugs Delivery System Market Facts & Figures by Country
3.4.1 North America Smart Pills and Drugs Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Smart Pills and Drugs Delivery System Sales by Country (2018-2029)
3.4.3 North America Smart Pills and Drugs Delivery System Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Smart Pills and Drugs Delivery System Market Facts & Figures by Country
3.5.1 Europe Smart Pills and Drugs Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Smart Pills and Drugs Delivery System Sales by Country (2018-2029)
3.5.3 Europe Smart Pills and Drugs Delivery System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Smart Pills and Drugs Delivery System Market Facts & Figures by Country
3.6.1 Asia Pacific Smart Pills and Drugs Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Smart Pills and Drugs Delivery System Sales by Country (2018-2029)
3.6.3 Asia Pacific Smart Pills and Drugs Delivery System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Smart Pills and Drugs Delivery System Market Facts & Figures by Country
3.7.1 Latin America Smart Pills and Drugs Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Smart Pills and Drugs Delivery System Sales by Country (2018-2029)
3.7.3 Latin America Smart Pills and Drugs Delivery System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Smart Pills and Drugs Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Smart Pills and Drugs Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Smart Pills and Drugs Delivery System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Smart Pills and Drugs Delivery System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Smart Pills and Drugs Delivery System Sales by Type (2018-2029)
4.1.1 Global Smart Pills and Drugs Delivery System Sales by Type (2018-2023)
4.1.2 Global Smart Pills and Drugs Delivery System Sales by Type (2024-2029)
4.1.3 Global Smart Pills and Drugs Delivery System Sales Market Share by Type (2018-2029)
4.2 Global Smart Pills and Drugs Delivery System Revenue by Type (2018-2029)
4.2.1 Global Smart Pills and Drugs Delivery System Revenue by Type (2018-2023)
4.2.2 Global Smart Pills and Drugs Delivery System Revenue by Type (2024-2029)
4.2.3 Global Smart Pills and Drugs Delivery System Revenue Market Share by Type (2018-2029)
4.3 Global Smart Pills and Drugs Delivery System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Smart Pills and Drugs Delivery System Sales by Application (2018-2029)
5.1.1 Global Smart Pills and Drugs Delivery System Sales by Application (2018-2023)
5.1.2 Global Smart Pills and Drugs Delivery System Sales by Application (2024-2029)
5.1.3 Global Smart Pills and Drugs Delivery System Sales Market Share by Application (2018-2029)
5.2 Global Smart Pills and Drugs Delivery System Revenue by Application (2018-2029)
5.2.1 Global Smart Pills and Drugs Delivery System Revenue by Application (2018-2023)
5.2.2 Global Smart Pills and Drugs Delivery System Revenue by Application (2024-2029)
5.2.3 Global Smart Pills and Drugs Delivery System Revenue Market Share by Application (2018-2029)
5.3 Global Smart Pills and Drugs Delivery System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Corporation Information
6.1.2 BD Description and Business Overview
6.1.3 BD Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 BD Smart Pills and Drugs Delivery System Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Corporation Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Smart Pills and Drugs Delivery System Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 HCmed Innovations
6.3.1 HCmed Innovations Corporation Information
6.3.2 HCmed Innovations Description and Business Overview
6.3.3 HCmed Innovations Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 HCmed Innovations Smart Pills and Drugs Delivery System Product Portfolio
6.3.5 HCmed Innovations Recent Developments/Updates
6.4 Adherium
6.4.1 Adherium Corporation Information
6.4.2 Adherium Description and Business Overview
6.4.3 Adherium Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Adherium Smart Pills and Drugs Delivery System Product Portfolio
6.4.5 Adherium Recent Developments/Updates
6.5 BIOCORP
6.5.1 BIOCORP Corporation Information
6.5.2 BIOCORP Description and Business Overview
6.5.3 BIOCORP Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 BIOCORP Smart Pills and Drugs Delivery System Product Portfolio
6.5.5 BIOCORP Recent Developments/Updates
6.6 Medtronic
6.6.1 Medtronic Corporation Information
6.6.2 Medtronic Description and Business Overview
6.6.3 Medtronic Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Medtronic Smart Pills and Drugs Delivery System Product Portfolio
6.6.5 Medtronic Recent Developments/Updates
6.7 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novartis AG Smart Pills and Drugs Delivery System Product Portfolio
6.7.5 Novartis AG Recent Developments/Updates
6.8 Novo Nordisk A/S
6.8.1 Novo Nordisk A/S Corporation Information
6.8.2 Novo Nordisk A/S Description and Business Overview
6.8.3 Novo Nordisk A/S Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Novo Nordisk A/S Smart Pills and Drugs Delivery System Product Portfolio
6.8.5 Novo Nordisk A/S Recent Developments/Updates
6.9 Amiko Digital Health
6.9.1 Amiko Digital Health Corporation Information
6.9.2 Amiko Digital Health Description and Business Overview
6.9.3 Amiko Digital Health Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Amiko Digital Health Smart Pills and Drugs Delivery System Product Portfolio
6.9.5 Amiko Digital Health Recent Developments/Updates
6.10 Boston Scientific Corporation
6.10.1 Boston Scientific Corporation Corporation Information
6.10.2 Boston Scientific Corporation Description and Business Overview
6.10.3 Boston Scientific Corporation Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Boston Scientific Corporation Smart Pills and Drugs Delivery System Product Portfolio
6.10.5 Boston Scientific Corporation Recent Developments/Updates
6.11 CeQur Simplicity
6.11.1 CeQur Simplicity Corporation Information
6.11.2 CeQur Simplicity Smart Pills and Drugs Delivery System Description and Business Overview
6.11.3 CeQur Simplicity Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.11.4 CeQur Simplicity Smart Pills and Drugs Delivery System Product Portfolio
6.11.5 CeQur Simplicity Recent Developments/Updates
6.12 Microchip Technology
6.12.1 Microchip Technology Corporation Information
6.12.2 Microchip Technology Smart Pills and Drugs Delivery System Description and Business Overview
6.12.3 Microchip Technology Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Microchip Technology Smart Pills and Drugs Delivery System Product Portfolio
6.12.5 Microchip Technology Recent Developments/Updates
6.13 FUJIFILM Holdings Corporation
6.13.1 FUJIFILM Holdings Corporation Corporation Information
6.13.2 FUJIFILM Holdings Corporation Smart Pills and Drugs Delivery System Description and Business Overview
6.13.3 FUJIFILM Holdings Corporation Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.13.4 FUJIFILM Holdings Corporation Smart Pills and Drugs Delivery System Product Portfolio
6.13.5 FUJIFILM Holdings Corporation Recent Developments/Updates
6.14 E3D Elcam Drug Delivery Devices
6.14.1 E3D Elcam Drug Delivery Devices Corporation Information
6.14.2 E3D Elcam Drug Delivery Devices Smart Pills and Drugs Delivery System Description and Business Overview
6.14.3 E3D Elcam Drug Delivery Devices Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.14.4 E3D Elcam Drug Delivery Devices Smart Pills and Drugs Delivery System Product Portfolio
6.14.5 E3D Elcam Drug Delivery Devices Recent Developments/Updates
6.15 Koninklijke Philips N.V
6.15.1 Koninklijke Philips N.V Corporation Information
6.15.2 Koninklijke Philips N.V Smart Pills and Drugs Delivery System Description and Business Overview
6.15.3 Koninklijke Philips N.V Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Koninklijke Philips N.V Smart Pills and Drugs Delivery System Product Portfolio
6.15.5 Koninklijke Philips N.V Recent Developments/Updates
6.16 H&T Presspart Manufacturing
6.16.1 H&T Presspart Manufacturing Corporation Information
6.16.2 H&T Presspart Manufacturing Smart Pills and Drugs Delivery System Description and Business Overview
6.16.3 H&T Presspart Manufacturing Smart Pills and Drugs Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.16.4 H&T Presspart Manufacturing Smart Pills and Drugs Delivery System Product Portfolio
6.16.5 H&T Presspart Manufacturing Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Smart Pills and Drugs Delivery System Industry Chain Analysis
7.2 Smart Pills and Drugs Delivery System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Smart Pills and Drugs Delivery System Production Mode & Process
7.4 Smart Pills and Drugs Delivery System Sales and Marketing
7.4.1 Smart Pills and Drugs Delivery System Sales Channels
7.4.2 Smart Pills and Drugs Delivery System Distributors
7.5 Smart Pills and Drugs Delivery System Customers
8 Smart Pills and Drugs Delivery System Market Dynamics
8.1 Smart Pills and Drugs Delivery System Industry Trends
8.2 Smart Pills and Drugs Delivery System Market Drivers
8.3 Smart Pills and Drugs Delivery System Market Challenges
8.4 Smart Pills and Drugs Delivery System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
